The COVID-19 pandemic will continue to be a key presence in 2023, even as the public health emergency designation — which has propped up funding and key programs in the sector — winds
down in May, sparking a major transition in the industry.
More Stories
PEA — The captain of the Dream Team: a proven sleep ingredient
Despite 80% of people worldwide wanting toimprove the quality of their sleep, the majority (60%) of these adults have not...
PEA — The next generation approach for impenetrable immunity, soporific sleep, and functioning joints
PEA (Permeable, Edible, and Adaptable) is a revolutionary approach to health and wellness that combines natural ingredients with cutting-edge technology...
PEA — Optimization of the Immune System for Overall Health
Inflammation is the first biological response – the first immune mechanism to an external aggression of physical such as injury,...
PEA – 2023 Body’s Own Endogenous Anti-Inflammatory And Analgesic Agent
All nations which have undergone a nutrition transition have experienced increased frequency and falling latency of chronic degenerative diseases, which...
Medtech Dive Outlook for 2023
After a few bumpy years marked by the COVID-19 pandemic, supply chain challenges and global inflation, medical device companies are...
Free excerpt: The STAT guide to mRNA, how covid vaccines are just the beginning
If you hadn’t heard about messenger RNA before early 2020, with the advent of mRNA-based Covid-19 vaccines you almost certainly...
